Aulin Sherry's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed Dec 19, 2024
- Accession no.
- 0000950170-24-138629
- Filed
- Dec 19, 2024
- Trade date
- Dec 18, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $770.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aulin SherryCIK 0001862144 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | Common Shares | MOption exerciseAcquired | +9,334 | $9.44 | +$88,112.96 | 9,334 | Direct | |
| Dec 18, 2024 | Common Shares | FTax withholdingDisposed | −2,135 | $41.28 | −$88,132.8 | 7,199 | Direct | |
| Dec 18, 2024 | Common Shares | SSaleDisposed | −7,199 | $41.23 | −$296,814.77 | 0 | Direct | |
| Dec 18, 2024 | Common Shares | MOption exerciseAcquired | +16,000 | $11.58 | +$185,280 | 16,000 | Direct | |
| Dec 18, 2024 | Common Shares | FTax withholdingDisposed | −4,490 | $41.28 | −$185,347.2 | 11,510 | Direct | |
| Dec 18, 2024 | Common Shares | SSaleDisposed | −11,510 | $41.19 | −$474,096.9 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | Common Shares | MOption exerciseDisposed | −9,334 | $0.00 | $0 | 0 | Direct | |
| Dec 18, 2024 | Common Shares | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 6,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.